Publications by authors named "David A Cox"

Claim this Profile
D
Dulaglutide and Glomerular Hyperfiltration, Proteinuria, and Albuminuria in Youth With Type 2 Diabetes: Post Hoc Analysis of the AWARD-PEDS Study.
Petter Bjornstad, Silva A Arslanian, Tamara S Hannon, Philip S Zeitler, Jennie L Francis, David A Cox

Diabetes Care· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twitter (X) in Medicine: Friend or Foe to the Field of Interventional Cardiology?
Mohammad Atif Rana, Grace Sorger, David A Cox, George D Dangas, Farshad Forouzandeh

J Soc Cardiovasc Angiogr Interv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DES.
Bahira Shahim, Björn Redfors, Thomas D Stuckey, Mengdan Liu, Zhipeng Zhou, David A Cox

J Am Heart Assoc· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of expanded dulaglutide weekly doses (3.0 mg and 4.5 mg) on cardiovascular disease risk factors in participants with type 2 diabetes at increased cardiovascular disease risk: a post hoc analysis of the AWARD-11 study.
David A Cox, Hui Wang, Claudia Nicolay, Mary Angelyn Bethel

Diabetes Obes Metab· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycaemic efficacy of an expanded dose range of dulaglutide according to baseline glycated haemoglobin (HbA1c) subgroup: Post hoc analysis of AWARD-11.
Juan P Frias, Enzo Bonora, David A Cox, M Angelyn Bethel, Anita Y M Kwan

Diabetes Obes Metab· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Interventional Trials in Youth-Onset Type 2 Diabetes: Challenges and Opportunities.
Brooke M Currie, Timothy A Howell, Louis S Matza, David A Cox, Joseph A Johnston

Diabetes Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD-11 trial.
Juan P Frias, Enzo Bonora, Luis Nevárez Ruiz, Stanley H Hsia, Heike Jung, David A Cox

Diabetes Obes Metab· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD-11.
Enzo Bonora, Juan P Frias, Francisco J Tinahones, Joanna Van, Raleigh E Malik, David A Cox

Diabetes Obes Metab· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11).
Juan P Frias, Enzo Bonora, Luis Nevarez Ruiz, Ying G Li, Zhuoxin Yu, David A Cox

Diabetes Care· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES.
Katherine H Chau, Ajay J Kirtane, Rachel M Easterwood, Björn Redfors, Zixuan Zhang, David A Cox

JACC Cardiovasc Interv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hot topics in interventional cardiology: Proceedings from the society for cardiovascular angiography and interventions 2020 think tank.
Srihari S Naidu, Megan Coylewright, Beau M Hawkins, Perwaiz Meraj, Brian H Morray, David A Cox

Catheter Cardiovasc Interv· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy.
Geoffrey A Rubin, Ajay J Kirtane, Shmuel Chen, Björn Redfors, Giora Weisz, David A Cox

Catheter Cardiovasc Interv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort antler size signals environmental stress in a moderate climate.
Bronson K Strickland, P Grady Dixon, Phillip D Jones, Stephen Demarais, Nathan O Owen, David A Cox

Int J Biometeorol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta-analysis of disease progression rates in recent multicenter clinical trials.
Craig M McDonald, Gautam Sajeev, Zhiwen Yao, Erin McDonnell, Gary Elfring, David A Cox

Muscle Nerve· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study).
Björn Redfors, Shmuel Chen, Ori Ben-Yehuda, Xin Huang, Bernhard Witzenbichler, David A Cox

Am J Cardiol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hot topics in interventional cardiology: Proceedings from the Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Think Tank.
Srihari S Naidu, Matthew J Daniels, Sammy Elmariah, Santiago Garcia, Andrew J Klein, David A Cox

Catheter Cardiovasc Interv· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo-controlled trial in patients with type 2 diabetes using metformin.
Juan P Frias, Alan G Wynne, Beata Matyjaszek-Matuszek, Dagmar Bartaskova, David A Cox

Diabetes Obes Metab· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study.
Matthew T Finn, Björn Redfors, Dimitri Karmpaliotis, Ajay J Kirtane, Philip Green, David A Cox

Am Heart J· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo.
Santiago G Lago, Jakub Tomasik, Geertje F van Rees, Hannah Steeb, David A Cox

Sci Adv· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Should I Do?: Maintenance of Certification for All Cardiologists in 2019 and Beyond.
C Michael Valentine, David A Cox, Thomas F Deering, Randall C Starling

J Am Coll Cardiol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SCAI 2018 Think Tank Proceedings: "What should the role of the surgeon be in TAVR, both as a co-operator and in-patient evaluation for TAVR?
Jay S Giri, Molly Szerlip, Chandan Devireddy, David A Cox, Clifford Kavinsky

Catheter Cardiovasc Interv· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stents.
Christine J Chung, Ajay J Kirtane, Yiran Zhang, Bernhard Witzenbichler, Giora Weisz, David A Cox

Am Heart J· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents.
Akiko Maehara, Gary S Mintz, Bernhard Witzenbichler, Giora Weisz, Franz-Josef Neumann, David A Cox

Circ Cardiovasc Interv· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population.
Sorin J Brener, Ajay J Kirtane, Michael J Rinaldi, Thomas D Stuckey, Bernhard Witzenbichler, David A Cox

Circ Cardiovasc Interv· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study.
Gennaro Giustino, Björn Redfors, Ajay J Kirtane, Roxana Mehran, George D Dangas, David A Cox

JACC Cardiovasc Interv· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis